108 related articles for article (PubMed ID: 34130463)
21. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
Baig AM
ACS Chem Neurosci; 2020 May; 11(9):1204-1205. PubMed ID: 32343122
[TBL] [Abstract][Full Text] [Related]
22. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
Matías-Guiu J; Gomez-Pinedo U; Montero-Escribano P; Gomez-Iglesias P; Porta-Etessam J; Matias-Guiu JA
Neurologia (Engl Ed); 2020 Apr; 35(3):170-175. PubMed ID: 32299636
[TBL] [Abstract][Full Text] [Related]
23. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Entry Into the Central Nervous System by Neuroinvasive Pathogens.
Valizadeh N; Rudmann EA; Solomon IH; Mukerji SS
J Neuroophthalmol; 2022 Jun; 42(2):163-172. PubMed ID: 35195546
[TBL] [Abstract][Full Text] [Related]
25. Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome.
Baig AM
ACS Chem Neurosci; 2020 Dec; 11(24):4017-4020. PubMed ID: 33275404
[TBL] [Abstract][Full Text] [Related]
26. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.
Pacheco-Herrero M; Soto-Rojas LO; Harrington CR; Flores-Martinez YM; Villegas-Rojas MM; León-Aguilar AM; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Corniel-Taveras CN; Dominguez-García JJ; Blanco-Alvarez VM; Luna-Muñoz J
Front Neurol; 2021; 12():660087. PubMed ID: 33912129
[TBL] [Abstract][Full Text] [Related]
27. Can Covid-19 attack our nervous system?
Abdel Hafez SMN
J Chem Neuroanat; 2021 Nov; 117():102006. PubMed ID: 34324964
[TBL] [Abstract][Full Text] [Related]
28. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
McGowan EM; Haddadi N; Nassif NT; Lin Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
[TBL] [Abstract][Full Text] [Related]
29. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
[TBL] [Abstract][Full Text] [Related]
30. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
31. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms.
Sharma S; Jagadeesh H; Saxena A; Chakravarthy H; Devanathan V
J Biosci; 2021; 46(4):. PubMed ID: 34840148
[TBL] [Abstract][Full Text] [Related]
33. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
34. Research progress in nervous system damage caused by SARS
Huang P; Tang L; Ren Y; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1247-1254. PubMed ID: 33268588
[TBL] [Abstract][Full Text] [Related]
35. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
Emerg Infect Dis; 2021 May; 27(5):1446-1453. PubMed ID: 33797393
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2, an Underestimated Pathogen of the Nervous System.
Jakhmola S; Indari O; Chatterjee S; Jha HC
SN Compr Clin Med; 2020; 2(11):2137-2146. PubMed ID: 33015550
[TBL] [Abstract][Full Text] [Related]
37. [Microglial Regulation of Blood Brain Barrier, the Neuro-Immunological Interface].
Ikegami A; Wake H
Brain Nerve; 2021 Aug; 73(8):913-919. PubMed ID: 34376598
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 involvement in central nervous system tissue damage.
Haidar MA; Shakkour Z; Reslan MA; Al-Haj N; Chamoun P; Habashy K; Kaafarani H; Shahjouei S; Farran SH; Shaito A; Saba ES; Badran B; Sabra M; Kobeissy F; Bizri M
Neural Regen Res; 2022 Jun; 17(6):1228-1239. PubMed ID: 34782556
[TBL] [Abstract][Full Text] [Related]
39. Human stem cell models to study host-virus interactions in the central nervous system.
Harschnitz O; Studer L
Nat Rev Immunol; 2021 Jul; 21(7):441-453. PubMed ID: 33398129
[TBL] [Abstract][Full Text] [Related]
40. What SARS-CoV-2 does to our brains.
Aschman T; Mothes R; Heppner FL; Radbruch H
Immunity; 2022 Jul; 55(7):1159-1172. PubMed ID: 35777361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
